Ann: FY20 Annual Report and Audited Accounts, page-4

Trouble is, vaccine roll out may be slower in that part of the World, so positive announcements now may not translate to tangible protection in Thailand until mid next year. Lots a richer countries have paid big money and put a lot of pressure on companies to secure supply.

Biggest thing for me is the capital position. I'm just not convinced DNA will simply refinance etc. Yes it seemingly has low debt to assets and could be a good credit in normal circumstamces. However it didnt happen last time like that. I think it will cost another capital raising for a similar amount to the last one to pay off some debt and contribute to working capital for restart.

At least there may be a bit less cash burn going forward with a trickle of revenue coming in, plus better management focus, if you believe it.